Corporate | Rompharm Medicines, 15 years experience in the production of medicinal products for human use...

Rompharm

Rompharm Company, which has been serving in the international medicinal Hakkımızda

product market for 25 years, has taken its first steps in the pharmaceutical sector with its medical product promotion, sales and marketing activities in Russia and Belarus.

Rompharm Company began its operations in 2004, producing sterile solutions and suspensions in the form of non-sterile solutions and suspensions at its manufacturing facility, which has been granted GMP approval by the Romanian Health Authority for human medicinal product manufacturing operations.

Initially, the production capacity of 30 million units / year has been increased to 64 million units / yearin line with the demands of customers in the pharmaceutical market and by investing in high-tech equipment.

We are committed to protecting people's health and looking for happier and more hopeful eyes to them.

Decision to Produce Products in Turkish Medicine Market

In 2006, the second GMP approved production facility and in 2007, the third GMP approved production facility and the production of human medicine products were expanded;in the form of solid dosage forms and aseptically produced injection solutions.

In the following decades, it has begun to produce competitive prescription qualities and to produce pre-filled syringes and medicinal products in the form of perfusion solutions.

Rompharm Company has taken the decision to manufacture medicinal products for human consumption for the Turkish pharmaceutical market in parallel with production, sales and marketing operations carried out in Europe and CIS countries.

Today Rompharm Company exports human medicines to over 50 countries in Europe and Asia with its portfolio of over 100 products.

Total Production Caps 130 Million Pcs

At the end of 2015, Rompharm Pharmaceutical started production operations in our GMP approved production facility of Ministry of Health of Turkey.

Our production facility located in Çerkezköy Organized Industrial Zone Tekirdag has 4 production lines where sterile injectable solutions and medicinal products for human use in the form of sterile eye drops are produced.

The total production capacity of our facility is 130 million units / year. The licensing studies of injectable solutions and generic products in the form of eye drops, which we aim to present to the Turkish pharmaceutical market, continue at a rapid pace.

We aim to provide high quality services to the Turkish pharmaceutical market with our 15 year experience in the production of human medicinal products and our production facilities in Europe with high technology equipment park established in Turkey.

In our ophthalmic medical products market in Turkey, it is our primary goal to provide the first and second generic equivalent products that will be an alternative to the original products in the treatment areas such as glaucoma, ocular hypertension, eye infection and ophthalmia as soon as possible and to provide public benefit.
As an international pharmaceutical company, our priority is to maintain the quality, ethical standards and honesty provided at all production, sales and marketing operations we carry out at a high level.